Literature DB >> 29563206

High Prevalence of Toxigenic and Nontoxigenic Clostridium difficile Strains in Malaysia.

Thomas V Riley1,2,3, Deirdre A Collins4, Rina Karunakaran5, Maria Abdul Kahar5, Ariza Adnan5, Siti Asma Hassan6, Nadiah Hanim Zainul6, F R Mohammed Rustam7, Z Abd Wahab8, Ramliza Ramli9, Yeong Yeh Lee6, Hamimah Hassan5.   

Abstract

Accumulating evidence shows a high prevalence of Clostridium difficile in Southeast Asia associated with a range of clinical presentations. However, severe infections are rarely reported. We investigated C. difficile infection (CDI) across four hospitals in Kuala Lumpur and Kota Bharu, Malaysia. Enzyme immunoassays for glutamate dehydrogenase (GDH) and toxin A or B were performed on diarrheal stool specimens collected from patients in 2015 and 2016. Specimens were also cultured and isolates of C. difficile characterized by PCR ribotyping and detection of toxin genes. In total, 437 specimens were collected and fecal toxin was detected in 3.0%. A further 16.2% of specimens were GDH positive and toxin negative. After culture, toxigenic strains were isolated from 10.3% and nontoxigenic strains from 12.4% of specimens. The most prevalent PCR ribotypes (RTs) were RT 017 (20.0%) and RT 043 (10.0%). The high prevalence of RT 017 and nontoxigenic strains in Malaysia and in neighboring Thailand and Indonesia suggests that they localize to the region of Southeast Asia, with an implication that they may mediate the burden of CDI in the region.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Clostridium difficile; Malaysia; epidemiology; prevalence

Mesh:

Substances:

Year:  2018        PMID: 29563206      PMCID: PMC5971540          DOI: 10.1128/JCM.00170-18

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection.

Authors:  M J T Crobach; T Planche; C Eckert; F Barbut; E M Terveer; O M Dekkers; M H Wilcox; E J Kuijper
Journal:  Clin Microbiol Infect       Date:  2016-07-25       Impact factor: 8.067

2.  Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile Infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals.

Authors:  Becky A Miller; Luke F Chen; Daniel J Sexton; Deverick J Anderson
Journal:  Infect Control Hosp Epidemiol       Date:  2011-04       Impact factor: 3.254

3.  Clostridium difficile and Entamoeba histolytica infections in patients with colitis in the Philippines.

Authors:  Cirle Alcantara Warren; Eternity Labio; Raul Destura; Jesus Emmanuel Sevilleja; Jade D Jamias; Ma Lourdes O Daez
Journal:  Trans R Soc Trop Med Hyg       Date:  2012-05-30       Impact factor: 2.184

4.  Routine detection of Clostridium difficile in Western Australia.

Authors:  Deirdre A Collins; Thomas V Riley
Journal:  Anaerobe       Date:  2015-11-22       Impact factor: 3.331

5.  Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile.

Authors:  Denise Drudy; Norma Harnedy; Seamus Fanning; Margaret Hannan; Lorraine Kyne
Journal:  Infect Control Hosp Epidemiol       Date:  2007-06-29       Impact factor: 3.254

6.  Increasing incidence of Clostridium difficile infection, Australia, 2011-2012.

Authors:  Claudia Slimings; Paul Armstrong; Wendy D Beckingham; Ann L Bull; Lisa Hall; Karina J Kennedy; John Marquess; Rebecca McCann; Andrea Menzies; Brett G Mitchell; Michael J Richards; Paul C Smollen; Lauren Tracey; Irene J Wilkinson; Fiona L Wilson; Leon J Worth; Thomas V Riley
Journal:  Med J Aust       Date:  2014-03-17       Impact factor: 7.738

7.  Macro and micro diversity of Clostridium difficile isolates from diverse sources and geographical locations.

Authors:  Richard A Stabler; Lisa F Dawson; Esmeralda Valiente; Michelle D Cairns; Melissa J Martin; Elizabeth H Donahue; Thomas V Riley; J Glenn Songer; Ed J Kuijper; Kate E Dingle; Brendan W Wren
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240

8.  Prevalence and molecular epidemiology of Clostridium difficile infection in Indonesia.

Authors:  D A Collins; M H Gasem; T H Habibie; I G Arinton; P Hendriyanto; A P Hartana; T V Riley
Journal:  New Microbes New Infect       Date:  2017-05-04

9.  Prevalence and molecular epidemiology of Clostridium difficile infection in Thailand.

Authors:  P Putsathit; M Maneerattanaporn; P Piewngam; P Kiratisin; T V Riley
Journal:  New Microbes New Infect       Date:  2016-10-21

Review 10.  Epidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative Review.

Authors:  Lauren E Bloomfield; Thomas V Riley
Journal:  Infect Dis Ther       Date:  2016-07-01
View more
  9 in total

1.  Evaluation of glutamate dehydrogenase (GDH) and toxin A/B rapid tests for Clostridioides (prev. Clostridium) difficile diagnosis in a university hospital in Minas Gerais, Brazil.

Authors:  Carolina Pantuzza Ramos; Emily Oliveira Lopes; Amanda Nádia Diniz; Francisco Carlos Faria Lobato; Eduardo Garcia Vilela; Rodrigo Otávio Silveira Silva
Journal:  Braz J Microbiol       Date:  2020-05-04       Impact factor: 2.476

2.  Mild or Malign: Clinical Characteristics and Outcomes of Clostridium difficile Infection in Thailand.

Authors:  Korakrit Imwattana; Papanin Putsathit; Teera Leepattarakit; Pattarachai Kiratisin; Thomas V Riley
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

3.  Epidemiology of Clostridium (Clostridioides) difficile Infection in Southeast Asia.

Authors:  Peng An Khun; Thomas V Riley
Journal:  Am J Trop Med Hyg       Date:  2022-08-08       Impact factor: 3.707

4.  Antimicrobial Susceptibilities of Clostridium difficile Isolates from 12 Asia-Pacific Countries in 2014 and 2015.

Authors:  Tanya Lew; Papanin Putsathit; Kyung Mok Sohn; Yuan Wu; Kentaro Ouchi; Yoshikazu Ishii; Kazuhiro Tateda; Thomas V Riley; Deirdre A Collins
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

5.  Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study.

Authors:  Masoumeh Azimirad; Marcela Krutova; Abbas Yadegar; Shabnam Shahrokh; Meysam Olfatifar; Hamid Asadzadeh Aghdaei; Warren N Fawley; Mark H Wilcox; Mohammad Reza Zali
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

Review 6.  2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients.

Authors:  Massimo Sartelli; Stefano Di Bella; Lynne V McFarland; Sahil Khanna; Luis Furuya-Kanamori; Nadir Abuzeid; Fikri M Abu-Zidan; Luca Ansaloni; Goran Augustin; Miklosh Bala; Offir Ben-Ishay; Walter L Biffl; Stephen M Brecher; Adrián Camacho-Ortiz; Miguel A Caínzos; Shirley Chan; Jill R Cherry-Bukowiec; Jesse Clanton; Federico Coccolini; Maria E Cocuz; Raul Coimbra; Francesco Cortese; Yunfeng Cui; Jacek Czepiel; Zaza Demetrashvili; Isidoro Di Carlo; Salomone Di Saverio; Irina M Dumitru; Christian Eckmann; Edward H Eiland; Joseph D Forrester; Gustavo P Fraga; Jean L Frossard; Donald E Fry; Rita Galeiras; Wagih Ghnnam; Carlos A Gomes; Ewen A Griffiths; Xavier Guirao; Mohamed H Ahmed; Torsten Herzog; Jae Il Kim; Tariq Iqbal; Arda Isik; Kamal M F Itani; Francesco M Labricciosa; Yeong Y Lee; Paul Juang; Aleksandar Karamarkovic; Peter K Kim; Yoram Kluger; Ari Leppaniemi; Varut Lohsiriwat; Gustavo M Machain; Sanjay Marwah; John E Mazuski; Gokhan Metan; Ernest E Moore; Frederick A Moore; Carlos A Ordoñez; Leonardo Pagani; Nicola Petrosillo; Francisco Portela; Kemal Rasa; Miran Rems; Boris E Sakakushev; Helmut Segovia-Lohse; Gabriele Sganga; Vishal G Shelat; Patrizia Spigaglia; Pierre Tattevin; Cristian Tranà; Libor Urbánek; Jan Ulrych; Pierluigi Viale; Gian L Baiocchi; Fausto Catena
Journal:  World J Emerg Surg       Date:  2019-02-28       Impact factor: 5.469

7.  Clostridioides difficile infection in the Asia-Pacific region.

Authors:  Deirdre A Collins; Kyung Mok Sohn; Yuan Wu; Kentaro Ouchi; Yoshikazu Ishii; Briony Elliott; Thomas V Riley; Kazuhiro Tateda
Journal:  Emerg Microbes Infect       Date:  2019-12-24       Impact factor: 7.163

8.  Global evolutionary dynamics and resistome analysis of Clostridioides difficile ribotype 017.

Authors:  Korakrit Imwattana; Papanin Putsathit; Deirdre A Collins; Teera Leepattarakit; Pattarachai Kiratisin; Thomas V Riley; Daniel R Knight
Journal:  Microb Genom       Date:  2022-03

Review 9.  The Current Knowledge on Clostridioides difficile Infection in Patients with Inflammatory Bowel Diseases.

Authors:  Alina Boeriu; Adina Roman; Crina Fofiu; Daniela Dobru
Journal:  Pathogens       Date:  2022-07-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.